홈 › 유방암 › 워싱턴 D.C. › Washington
DC Washington의 유방암 임상 시험
유방암 관련 연구 46개가 Washington 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
피험자 모집 중관찰 연구
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
The Vanguard Study: Testing a New Way to Screen for Cancer
피험자 모집 중건강한 지원자 환영
- Walter Reed National Military Medical Center, Bethesda · 7마일 거리
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
피험자 모집 중3상
- Georgetown University Medical Center, Washington D.C.
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
피험자 모집 중2상
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
피험자 모집 중관찰 연구
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
피험자 모집 중3상
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Maryland Oncology Hematology P A, Silver Spring · 7마일 거리
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
피험자 모집 중관찰 연구건강한 지원자 환영
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7마일 거리
Genomic Services Research Program
피험자 모집 중관찰 연구
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Older Breast Cancer Patients: Risk for Cognitive Decline
피험자 모집 중관찰 연구건강한 지원자 환영
- Georgetown University, Washington D.C.
Collection of Blood From Patients With Cancer
피험자 모집 중관찰 연구건강한 지원자 환영
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
피험자 모집 중2상
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
피험자 모집 중3상
- Holy Cross Hospital ( Site 0073), Silver Spring · 7마일 거리
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
피험자 모집 중2상
- The George Washington Medical facility Associates, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
피험자 모집 중3상
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7마일 거리
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
피험자 모집 중3상
- Georgetown Uni Hospital, Washington D.C.
- Medstar Research Institute, Hyattsville · 6마일 거리
Identifying Patterns in the Breath of Individuals With Breast Cancer
피험자 모집 중관찰 연구건강한 지원자 환영
- GW Comprehensive Breast Center, Washington D.C.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
피험자 모집 중3상
- Georgetown University Medical Center, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
- 외 1개
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
피험자 모집 중1상
- MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
피험자 모집 중1/2상
- Georgetown University, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
피험자 모집 중3상
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7마일 거리
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
피험자 모집 중3상
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- 외 5개
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd
피험자 모집 중2상
- Georgetown University Medical Center, Washington D.C.
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)
피험자 모집 중
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming
피험자 모집 중
- Sibley Memorial Hospital, Washington D.C.
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
피험자 모집 중3상
- Sibley Memorial Hospital, Washington D.C.
Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
피험자 모집 중1/2상
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
피험자 모집 중
- Walter Reed National Military Medical Center, Bethesda · 7마일 거리
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
피험자 모집 중3상
- Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
E-Mindfulness Approaches for Living After Breast Cancer
피험자 모집 중3상
- Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- 외 2개
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
피험자 모집 중관찰 연구건강한 지원자 환영
- National Institutes of Health Clinical Center, Bethesda · 7마일 거리
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
피험자 모집 중2상
- National Institute of Health Clinical Center, Bethesda · 7마일 거리
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
피험자 모집 중3상
- American Oncology Partners, P.A., Bethesda · 7마일 거리
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
피험자 모집 중2상
- Georgetown University Medical Center, Washington D.C.
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
피험자 모집 중3상
- MedStar Washington Hospital Center, Washington D.C.
- Maryland Oncology Hematology P.A., Silver Spring · 7마일 거리
- Maryland Oncology Hematology P.A., Bethesda · 7마일 거리
- 외 1개
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
피험자 모집 중3상
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- George Washington University Medical Center, Washington D.C.
- 외 2개
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
피험자 모집 중관찰 연구건강한 지원자 환영
- Cancer Support Community Research & Training Institute, Washington D.C.
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
피험자 모집 중2상
- Georgetown University, Washington D.C.
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
피험자 모집 중2상
- George Washington-Medical Faculty Associates, Washington D.C.
The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer
피험자 모집 중
- Sibley Memorial Hospital, Washington D.C.
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
피험자 모집 중관찰 연구
- Holy Cross Hospital - Silver Spring, Silver Spring · 7마일 거리
- The Center for Cancer and Blood Disorders - Bethesda, Bethesda · 7마일 거리
Study in Patients With Breast Cancer Leptomeningeal Metastasis
피험자 모집 중관찰 연구
- Sibley Memorial Hospital, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Silver Spring · 7마일 거리
- Massive Bio SYNERGY-AI site, Bethesda · 7마일 거리
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
피험자 모집 중
- Georgetown University, Washington D.C.
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
피험자 모집 중건강한 지원자 환영
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
피험자 모집 중관찰 연구
- Maryland Oncology Hematology, PA, Silver Spring · 7마일 거리
- Maryland Oncology Hematology - Bethesda, Bethesda · 7마일 거리
CtDNA Based MRD Testing for NAC Monitoring in TNBC
피험자 모집 중관찰 연구
- George Washington University, Washington D.C.
다른 도시의 유방암 시험
- New York City, NY연구 136개
- Houston, TX연구 126개
- Boston, MA연구 112개
- Nashville, TN연구 81개
- Los Angeles, CA연구 73개
- Edison, NJ연구 68개
- St. Louis, MO연구 64개
- Queens, NY연구 64개
- Durham, NC연구 64개
- Chicago, IL연구 59개
- Philadelphia, PA연구 56개
- Dallas, TX연구 55개
Washington의 다른 연구
- 암 (전체)연구 58개
- 비소세포폐암연구 55개
- 전이성 암연구 43개
- 폐암연구 41개
- 전립선암연구 38개
- 비만연구 33개
- 대장직장암연구 29개
- 심혈관 질환연구 28개
- 방광암연구 26개
- 급성 골수성 백혈병연구 24개
- 난소암연구 23개
- 림프종연구 23개
ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.